Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients

Abstract

Brain atrophy measurement can provide an estimate of the amount of tissue destruction due to the pathologic processes in multiple sclerosis. The potential usefulness of atrophy as a marker of disease progression depends upon the concurrent and predictive relationships between atrophy and disability. A follow-up study was performed to measure atrophy and disability scores in patients from the Multiple Sclerosis Collaborative Research Group's phase III trial of IFNb-1a (Avonex) in relapsing-remitting multiple sclerosis. New data were obtained on 160 out of 172 eligible patients from the original trial were enrolled in the follow-up study approximately 8 years after randomization. The follow-up visit consisted of several tests and questionnaires including a clinical exam to determine Expanded Disability Status Score (EDSS) and Multiple Sclerosis Functional Composite (MSFC), and a magnetic resonance imaging exam to calculate the brain parenchymal fraction. Brain parenchymal fraction was correlated with both EDSS and MSFC at each of the four time points for which data were available (baseline 1, 2 and 8 years). Furthermore, the change in BPF was correlated with the changes in disability scores from the end of the phase III trial to the follow-up exam. These data suggest that brain atrophy may be a useful and clinically relevant marker of disease progression in relapsing-remitting MS.

Keywords

multiple sclerosis magnetic resonance imaging brain atrophy

Get full access to this article

View all access options for this article.

References

Simon JH et al. (1999) A longitudinal study of brain atrophy in relapsing multiple sclerosis . Neurology 53: 139-148 .

Losseff NA et al. (1996) Progressive cerebral atrophy in multiple sclerosis A serial MRI study . Brain 119: 2009-2019 .

Rao SM et al. (1985) Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment . Arch Neurol 42: 678-682 .

Hohol SJ et al. (1997) Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis . Arch Neurol 54: 1018-1025 .

Rudick RA et al. (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS . Neurology 53: 1698-1704 .

Ge Y et al. (2000) Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: Quantitative MR assessment . Neurology 54: 813-817 .

Trapp B et al. (1998) Axonal transection in the lesions of multiple sclerosis . New Engl J Med 338: 278-285 .

Fu L et al. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis . Brain 121: 103-113 .

Matthews PM et al. (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy . Brain 119: 715-722 .

10.

Trapp BD , Ransohoff RM , Fisher E , Rudick RA. (1999) Neurodegeneration in multiple sclerosis: relationship to neurological disability . Neuroscientist 5: 48-57 .

11.

Jacobs LD et al. (1995) A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients . Multiple Sclerosis 1: 118-135 .

12.

Fisher E et al. (1997) Knowledge-based 3D segmentation of MR images for quantitative MS lesion tracking . Proc SPIE (Medical Imaging 1997: Image Processing) 3034: 599-610 .

13.

Rudick R et al. (1997) Recommendations from the clinical outcomes assessment task force of the National Multiple Sclerosis Society . Ann Neurol 42: 379-382 .

14.

Losseff NA et al. (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression . Brain 119: 701-708 .

15.

Liu C et al. (1999) Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis . J Neurol Neurosurg Psychiatry 66: 323-330 .

16.

Filippi M et al. (1998) Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis . J Neurol Sci 158: 148-153 .

17.

Ge Y et al. (2000) Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis . Radiology 214: 665-670 .

18.

Guttman CRG et al. (2000) Variability of brain atrophy in multiple sclerosis . Proc Int Soc Magnet Reson Med 1188-1188 (Abstract).